Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
Metrics to compare | FLGC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFLGCPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.7x | −0.9x | 11.5x | |
PEG Ratio | −0.01 | 0.00 | 0.03 | |
Price / Book | 2.8x | 0.7x | 1.5x | |
Price / LTM Sales | 0.2x | 0.4x | 0.9x | |
Upside (Analyst Target) | - | 21.7% | 22.3% | |
Fair Value Upside | Unlock | 23.6% | 12.0% | Unlock |